Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
Signe Westring Worm(University of Copenhagen), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Wafaa El‐Sadr(Columbia University Irving Medical Center), Ian Weller(University College London), Ole Kirk(University of Copenhagen), Éric Fontas(Université Côte d'Azur), Nina Friis‐Møller(University of Copenhagen), François Dabis(Université de Bordeaux), Rainer Weber(Georg Simon Ohm University of Applied Sciences Nuremberg), Antonella d’Arminio Monforte(University of Milan), Matthew Law(UNSW Sydney), Caroline Sabin(Primary Health Care), Peter Reiss(Amsterdam Institute for Global Health and Development), Stéphane De Wit(Université Libre de Bruxelles), Andrew Phillips(Wake Forest University)
Cited by 649
Related Papers
Antiretroviral Treatment of Adult HIV Infection
|JAMA|2012|2.5k
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
|The Journal of Infectious Diseases|2011|1.1k